Sara Coca Membribes, Clinical Research Fellow to Prof Powles at Barts Health NHS Trust, shared a post on X:
”HER2 has become a key target in urothelial carcinoma, although its definition is still not standardised.
Molecular subtype + temporal heterogeneity seem to play a role, and HER family co-expression may also be relevant.”
Title: HER2 in urothelial cancer: clinical speed outpacing diagnostic clarity
Authors: Emanuele Crupi, Filippo Pederzoli, Robert A. Huddart, Cheng Liang, Daniele Raggi
Other Articles Featuring Sara Coca Membribes on OncoDaily.